| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/07/1996 | EP0724588A1 Drug binding protein |
| 08/07/1996 | EP0724573A1 Pyrimidinones as antiarthritic and anti-inflammatories |
| 08/07/1996 | EP0724570A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 08/07/1996 | EP0724566A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
| 08/07/1996 | EP0724456A1 Antibodies to cd40 |
| 08/07/1996 | EP0724435A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 08/07/1996 | EP0724387A1 Treatment of chronic anti-inflammatory diseases by angiotension ii receptor antagonists |
| 08/07/1996 | CN1128531A Therapeutic compound-fatty acid conjugates |
| 08/07/1996 | CN1128262A Substituted biphenyl isoxazole sulfonamides |
| 08/07/1996 | CN1128260A New piperidine compounds, process for their preparation and the pharmaceutical compositions which contain them |
| 08/07/1996 | CN1128259A A process for preparing substituted methane-sulphonamide sulphate and solvates thereof |
| 08/06/1996 | US5543410 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof |
| 08/06/1996 | US5543140 Method and use of IL-1α |
| 08/01/1996 | WO1996023067A1 Human interleukin-1 receptor accessory protein |
| 08/01/1996 | WO1996022966A1 Cell adhesion inhibitors |
| 08/01/1996 | WO1996022793A1 Gene transfer for treating a connective tissue of a mammalian host |
| 08/01/1996 | CA2211833A1 Gene transfer for treating a connective tissue of a mammalian host |
| 08/01/1996 | CA2211181A1 Cell adhesion inhibitors |
| 08/01/1996 | CA2210724A1 Human interleukin-1 receptor accessory protein |
| 07/31/1996 | EP0723969A1 Phosphonocarboxylic acid derivatives and their use in treating degenerative articular ailments |
| 07/31/1996 | EP0723962A1 Arylalkyl-thiadiazinones |
| 07/31/1996 | EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them |
| 07/31/1996 | EP0723555A1 Chimeric proteins which block complement activation |
| 07/31/1996 | EP0723552A1 Oligopeptides derived from c-reactive protein fragments |
| 07/31/1996 | EP0723447A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 07/31/1996 | EP0648223A4 Substituted lactose derivatives as cell adhesion inhibitors. |
| 07/31/1996 | CN1128047A Recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 07/31/1996 | CN1128029A Thiazole derivatives as lipoxygenase inhibitors |
| 07/31/1996 | CN1127757A New tetrahydropyran compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
| 07/30/1996 | US5541288 Peptide having elastase inhibitory activity and producing method thereof |
| 07/30/1996 | US5541219 Antiinflammatory agents; aids |
| 07/30/1996 | US5541202 New leukotriene-B4 Antagonists and their use as pharmaceutical agents |
| 07/30/1996 | US5541195 1-acylpiperidine compounds |
| 07/30/1996 | US5541192 Treating restinosis |
| 07/30/1996 | US5541191 Treating pulmonary inflamation |
| 07/30/1996 | US5541183 Ginkgolide derivatives |
| 07/30/1996 | US5541171 Orally administrable pharmaceutical composition |
| 07/30/1996 | US5541170 Orally administrable pharmaceutical compositions |
| 07/30/1996 | US5541168 Proteolytic enzyme inhibitors; degenerative diseases; respiratory, skin, genetic and gastrointestinal disorders; antiarrthritic and -inflammatory agents; genetic diseases |
| 07/30/1996 | US5540930 Nonagglomerating suspension |
| 07/26/1996 | CA2167979A1 Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders |
| 07/25/1996 | WO1996022371A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
| 07/25/1996 | WO1996022306A1 Novel peptide |
| 07/25/1996 | WO1996022303A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | WO1996022108A1 The use of activated protein c for preparing a pharmaceutical preparation |
| 07/25/1996 | WO1996005209A3 Sialic acid/fucose based medicaments |
| 07/25/1996 | CA2210500A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | CA2209931A1 The use of activated protein c for preparing a pharmaceutical preparation |
| 07/25/1996 | CA2207086A1 G protein-coupled receptor gene |
| 07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
| 07/24/1996 | EP0722944A1 2-9-Disubstituted Purin-6-ones |
| 07/24/1996 | EP0722943A1 9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 07/24/1996 | EP0722937A1 2,8-Disubstituted quinazolinone |
| 07/24/1996 | EP0722928A1 Bicyclic-aromatic compounds with strong biologic activity, pharmaceutical and cosmetic compositions containing them and uses thereof |
| 07/24/1996 | EP0722738A2 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 07/24/1996 | EP0722448A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 07/24/1996 | EP0722438A1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 07/24/1996 | EP0722434A1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 07/24/1996 | EP0722334A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide |
| 07/24/1996 | EP0722322A1 Compounds, compositions and treatment of allergies and inflammation therewith |
| 07/24/1996 | EP0581954B1 Use of alpha-hydroxyketoalkyl derivatives as protective light filters |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/24/1996 | CN1127138A External sponge bath agent for reducing fever and preparation and application thereof |
| 07/24/1996 | CN1127116A New composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effec |
| 07/23/1996 | US5539128 Compounds for inhibiting leukotriene receptors as antiasmatics, antiarthritics, skin disorders, antiulcer agents or cardiovascular disorders |
| 07/23/1996 | US5539000 Spray-chilled nabumetone |
| 07/23/1996 | US5538986 Tricyclic derivatives, compositions and methods of use |
| 07/23/1996 | US5538969 4-amino derivatives of 5-substituted mycophenolic acid |
| 07/23/1996 | CA2001996C Method of treatment for interstitial cystitis |
| 07/20/1996 | CA2167353A1 2,9-disubstituted purin-6-ones |
| 07/20/1996 | CA2167349A1 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 07/20/1996 | CA2167345A1 2,8-disubstituted quinazolinones |
| 07/18/1996 | WO1996021667A1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| 07/18/1996 | WO1996021661A1 Piperidine derivatives having tachykinin antagonist activity |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021638A1 Novel compounds |
| 07/18/1996 | WO1996021462A1 Pharmaceutical compositions comprising a superoxide dismutase |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996021435A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 07/18/1996 | WO1996008569A3 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/18/1996 | CA2210322A1 Novel compounds |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209895A1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| 07/18/1996 | CA2209125A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 07/17/1996 | EP0721939A1 N-arylalkylphenylacetamide derivatives |
| 07/17/1996 | EP0721501A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 07/17/1996 | EP0721352A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 07/17/1996 | EP0721335A1 Mycophenolate mofetil high dose oral suspensions |
| 07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
| 07/16/1996 | US5536747 Enzyme inhibitors |
| 07/16/1996 | US5536730 Imidazonaphthyridine derivatives |
| 07/16/1996 | US5536641 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells |
| 07/11/1996 | WO1996020957A1 Anti-inflammatory cd14 polypeptides |
| 07/11/1996 | WO1996020956A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | WO1996020948A1 Human pak65 |
| 07/11/1996 | WO1996020930A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | WO1996020926A1 Substituted imides as tnf inhibitors |
| 07/11/1996 | WO1996020918A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | WO1996020915A1 Novel immunotherapeutic aryl amides |
| 07/11/1996 | WO1996020914A1 Tricyclic retinoids, methods for their production and use |